Fig. 1.
Fig. 1. Schematic diagrams of in vivo experiments in leukemic mice. (A) Mice were injected with wild-type WEHI-3B cells and survival was measured. (B) Mice were injected with irradiated WEHI-3B–lacZ, WEHI-3B–GM-CSF, WEHI-3B–GM-CSF plus WEHI-3B–IL-4, or WEHI-3B–GM-CSF plus WEHI-3B–TNF cells. One week later, mice were injected with wild-type WEHI-3B cells and survival was measured. (C) One group of mice was injected with wild-type WEHI-3B cells. A second group of mice was injected with irradiated, modified cells as described in (B), above. After 7 days, the latter mice were killed and BMMNCs from these animals were injected into the first group of mice.

Schematic diagrams of in vivo experiments in leukemic mice. (A) Mice were injected with wild-type WEHI-3B cells and survival was measured. (B) Mice were injected with irradiated WEHI-3B–lacZ, WEHI-3B–GM-CSF, WEHI-3B–GM-CSF plus WEHI-3B–IL-4, or WEHI-3B–GM-CSF plus WEHI-3B–TNF cells. One week later, mice were injected with wild-type WEHI-3B cells and survival was measured. (C) One group of mice was injected with wild-type WEHI-3B cells. A second group of mice was injected with irradiated, modified cells as described in (B), above. After 7 days, the latter mice were killed and BMMNCs from these animals were injected into the first group of mice.

Close Modal

or Create an Account

Close Modal
Close Modal